Literature DB >> 20452950

Structural biology of the T-cell receptor: insights into receptor assembly, ligand recognition, and initiation of signaling.

Kai W Wucherpfennig1, Etienne Gagnon, Melissa J Call, Eric S Huseby, Matthew E Call.   

Abstract

The T-cell receptor (TCR)-CD3 complex serves as a central paradigm for general principles of receptor assembly, ligand recognition, and signaling in the immune system. There is no other receptor system that matches the diversity of both receptor and ligand components. The recent expansion of the immunological structural database is beginning to identify key principles of MHC and peptide recognition. The multicomponent assembly of the TCR complex illustrates general principles used by many receptors in the immune system, which rely on basic and acidic transmembrane residues to guide assembly. The intrinsic binding of the cytoplasmic domains of the CD3epsilon and zeta chains to the inner leaflet of the plasma membrane represents a novel mechanism for control of receptor activation: Insertion of critical CD3epsilon tyrosines into the hydrophobic membrane core prevents their phosphorylation before receptor engagement.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20452950      PMCID: PMC2845206          DOI: 10.1101/cshperspect.a005140

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  74 in total

1.  Stoichiometry of the T-cell receptor-CD3 complex and key intermediates assembled in the endoplasmic reticulum.

Authors:  Matthew E Call; Jason Pyrdol; Kai W Wucherpfennig
Journal:  EMBO J       Date:  2004-05-20       Impact factor: 11.598

2.  Membrane protein association by potential intramembrane charge pairs.

Authors:  P Cosson; S P Lankford; J S Bonifacino; R D Klausner
Journal:  Nature       Date:  1991-05-30       Impact factor: 49.962

Review 3.  Static and dynamic lipid asymmetry in cell membranes.

Authors:  P F Devaux
Journal:  Biochemistry       Date:  1991-02-05       Impact factor: 3.162

4.  Lysine 271 in the transmembrane domain of the T-cell antigen receptor beta chain is necessary for its assembly with the CD3 complex but not for alpha/beta dimerization.

Authors:  A Alcover; R A Mariuzza; M Ermonval; O Acuto
Journal:  J Biol Chem       Date:  1990-03-05       Impact factor: 5.157

5.  The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens.

Authors:  P J Bjorkman; M A Saper; B Samraoui; W S Bennett; J L Strominger; D C Wiley
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

6.  Antigen receptor tail clue.

Authors:  M Reth
Journal:  Nature       Date:  1989-03-30       Impact factor: 49.962

7.  Colocalized transmembrane determinants for ER degradation and subunit assembly explain the intracellular fate of TCR chains.

Authors:  J S Bonifacino; P Cosson; R D Klausner
Journal:  Cell       Date:  1990-11-02       Impact factor: 41.582

8.  Assembly and function of the T cell antigen receptor. Requirement of either the lysine or arginine residues in the transmembrane region of the alpha chain.

Authors:  R S Blumberg; B Alarcon; J Sancho; F V McDermott; P Lopez; J Breitmeyer; C Terhorst
Journal:  J Biol Chem       Date:  1990-08-15       Impact factor: 5.157

9.  Structure of the T-cell antigen receptor: evidence for two CD3 epsilon subunits in the T-cell receptor-CD3 complex.

Authors:  R S Blumberg; S Ley; J Sancho; N Lonberg; E Lacy; F McDermott; V Schad; J L Greenstein; C Terhorst
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

10.  Structure of the T cell antigen receptor (TCR): two CD3 epsilon subunits in a functional TCR/CD3 complex.

Authors:  A de la Hera; U Müller; C Olsson; S Isaaz; A Tunnacliffe
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

View more
  61 in total

Review 1.  Immunoreceptor signaling.

Authors:  Lawrence E Samelson
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-12-01       Impact factor: 10.005

Review 2.  New Strategies in Engineering T-cell Receptor Gene-Modified T cells to More Effectively Target Malignancies.

Authors:  Thomas M Schmitt; Ingunn M Stromnes; Aude G Chapuis; Philip D Greenberg
Journal:  Clin Cancer Res       Date:  2015-10-13       Impact factor: 12.531

3.  Biologically active LIL proteins built with minimal chemical diversity.

Authors:  Erin N Heim; Jez L Marston; Ross S Federman; Anne P B Edwards; Alexander G Karabadzhak; Lisa M Petti; Donald M Engelman; Daniel DiMaio
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-10       Impact factor: 11.205

Review 4.  T-Cell Receptor-Based Immunotherapy for Hematologic Malignancies.

Authors:  Melinda A Biernacki; Michelle Brault; Marie Bleakley
Journal:  Cancer J       Date:  2019 May/Jun       Impact factor: 3.360

5.  Single-chain VαVβ T-cell receptors function without mispairing with endogenous TCR chains.

Authors:  D H Aggen; A S Chervin; T M Schmitt; B Engels; J D Stone; S A Richman; K H Piepenbrink; B M Baker; P D Greenberg; H Schreiber; D M Kranz
Journal:  Gene Ther       Date:  2011-07-14       Impact factor: 5.250

6.  Unusual biophysics of immune signaling-related intrinsically disordered proteins.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2010-10

Review 7.  Inside the microcluster: antigen receptor signalling viewed with molecular imaging tools.

Authors:  Pavel Tolar
Journal:  Immunology       Date:  2011-05-17       Impact factor: 7.397

8.  Ionic CD3-Lck interaction regulates the initiation of T-cell receptor signaling.

Authors:  Lunyi Li; Xingdong Guo; Xiaoshan Shi; Changting Li; Wei Wu; Chengsong Yan; Haopeng Wang; Hua Li; Chenqi Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-28       Impact factor: 11.205

Review 9.  Re-adapting T cells for cancer therapy: from mouse models to clinical trials.

Authors:  Ingunn M Stromnes; Thomas M Schmitt; Aude G Chapuis; Sunil R Hingorani; Philip D Greenberg
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

Review 10.  Bispecific T-Cell Redirection versus Chimeric Antigen Receptor (CAR)-T Cells as Approaches to Kill Cancer Cells.

Authors:  William R Strohl; Michael Naso
Journal:  Antibodies (Basel)       Date:  2019-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.